Suppr超能文献

根治性放疗在恶性胸膜间皮瘤治疗中的作用:系统评价。

The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.

机构信息

Beatson West of Scotland Cancer Centre, Glasgow, UK; Institute of Cancer Sciences, University of Glasgow, UK.

Beatson West of Scotland Cancer Centre, Glasgow, UK.

出版信息

Radiother Oncol. 2017 Oct;125(1):1-12. doi: 10.1016/j.radonc.2017.08.003. Epub 2017 Aug 28.

Abstract

Malignant pleural mesothelioma (MPM) is a devastating disease with limited treatment options and a dismal prognosis. Attempts to employ radical radiotherapy in this disease have been limited by the complex shape of the pleura and the dose restrictions necessitated by the close proximity of radiosensitive structures. Recent shifts towards a 'lung sparing' surgical approach in MPM have further heightened these challenges. The aim of this systematic review is to assess recent advances in radiotherapy planning and delivery, to ascertain how these developments have impacted on the feasibility of delivering photon-based, high-dose radiotherapy with radical intent in MPM. Three electronic databases were searched and a total of 249 articles reviewed. The challenge of generating high quality, practice-defining data for diseases such as MPM was highlighted by the identification of just two randomised studies. Much of the literature consisted of low quality, retrospective data with small cohorts and inconsistent reporting on radiotherapy techniques and dosimetry. Nevertheless, a number of prospective phase II studies were identified to suggest that radical doses of radiotherapy can be delivered safely after a lung sparing procedure in MPM, reporting encouraging survival data and acceptable levels of toxicity.

摘要

恶性胸膜间皮瘤(MPM)是一种破坏性疾病,治疗选择有限,预后不佳。由于胸膜的复杂形状以及靠近放射敏感结构所必需的剂量限制,在该疾病中尝试采用根治性放疗受到限制。最近在 MPM 中向“肺保护”手术方法的转变进一步加剧了这些挑战。本系统评价的目的是评估放射治疗计划和实施的最新进展,以确定这些进展如何影响在 MPM 中用根治性意图提供基于光子的高剂量放疗的可行性。对三个电子数据库进行了搜索,并对总共 249 篇文章进行了综述。仅确定了两项随机研究,突出了为 MPM 等疾病生成高质量、具有实践定义的数据的挑战。大部分文献为低质量的回顾性数据,队列规模较小,放射治疗技术和剂量学的报告不一致。尽管如此,仍确定了一些前瞻性 II 期研究,表明在 MPM 中进行肺保护手术后可以安全地给予根治剂量的放疗,报告了令人鼓舞的生存数据和可接受的毒性水平。

相似文献

1
The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
Radiother Oncol. 2017 Oct;125(1):1-12. doi: 10.1016/j.radonc.2017.08.003. Epub 2017 Aug 28.
2
Radiotherapy for malignant pleural mesothelioma.
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD003880. doi: 10.1002/14651858.CD003880.pub4.
3
Radical multimodality therapy for malignant pleural mesothelioma.
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD012605. doi: 10.1002/14651858.CD012605.pub2.
4
Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma.
Expert Rev Respir Med. 2017 Aug;11(8):649-660. doi: 10.1080/17476348.2017.1338951. Epub 2017 Jun 12.
6
Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice.
Lung Cancer. 2009 Nov;66(2):150-6. doi: 10.1016/j.lungcan.2009.06.014. Epub 2009 Jul 23.
7
The role of radiation therapy in malignant pleural mesothelioma: a systematic review.
Radiother Oncol. 2006 Jul;80(1):13-8. doi: 10.1016/j.radonc.2006.06.002. Epub 2006 Jul 3.
8
Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review.
Thorax. 2023 Apr;78(4):409-417. doi: 10.1136/thoraxjnl-2021-218214. Epub 2022 Apr 11.

引用本文的文献

1
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study.
Cancers (Basel). 2025 Aug 27;17(17):2797. doi: 10.3390/cancers17172797.
3
Contemporary management of mesothelioma.
Breathe (Sheff). 2024 Jul 16;20(2):230175. doi: 10.1183/20734735.0175-2023. eCollection 2024 Jun.
4
Controversies in the role of radiotherapy in pleural mesothelioma.
Transl Lung Cancer Res. 2021 Apr;10(4):2079-2087. doi: 10.21037/tlcr-20-583.
5
A Review of Pharmacologic Management in the Treatment of Mesothelioma.
Curr Treat Options Oncol. 2021 Jan 12;22(2):14. doi: 10.1007/s11864-020-00807-y.
6
Cardiotoxicity of mediastinal radiotherapy.
Rep Pract Oncol Radiother. 2019 Nov-Dec;24(6):629-643. doi: 10.1016/j.rpor.2019.09.002. Epub 2019 Oct 30.
7
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.
Adv Respir Med. 2019;87(5):289-297. doi: 10.5603/ARM.2019.0051.
8
Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Strahlenther Onkol. 2019 Jul;195(7):668-676. doi: 10.1007/s00066-019-01458-1. Epub 2019 Mar 26.
9
Progress in the Management of Malignant Pleural Mesothelioma in 2017.
J Thorac Oncol. 2018 May;13(5):606-623. doi: 10.1016/j.jtho.2018.02.021. Epub 2018 Mar 8.

本文引用的文献

2
Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
J Thorac Oncol. 2017 Jun;12(6):993-1000. doi: 10.1016/j.jtho.2017.02.026. Epub 2017 Mar 21.
3
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
Acta Oncol. 2016 Dec;55(12):1450-1455. doi: 10.1080/0284186X.2016.1234066. Epub 2016 Oct 12.
6
Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?
Lancet Oncol. 2016 Feb;17(2):e43-e44. doi: 10.1016/S1470-2045(16)00024-3.
7
Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
J Thorac Cardiovasc Surg. 2016 Feb;151(2):468-73. doi: 10.1016/j.jtcvs.2015.09.129. Epub 2015 Oct 19.
10
Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Strahlenther Onkol. 2016 Feb;192(2):102-8. doi: 10.1007/s00066-015-0901-8. Epub 2015 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验